BET inhibitor resistance emerges from leukaemia stem cells
暂无分享,去创建一个
Mark A. Dawson | Omar Abdel-Wahab | Alan F. Rubin | Anthony T. Papenfuss | Tony Kouzarides | Paul Yeh | Robert G. Ramsay | Philip D. Jeffrey | Ricky W. Johnstone | Sarah-Jane Dawson | S. Dawson | O. Abdel-Wahab | R. Prinjha | M. Dawson | T. Kouzarides | P. Jeffrey | A. Papenfuss | R. Johnstone | B. Huntly | R. Ramsay | K. Stanley | O. Gilan | Richard Gregory | G. Giotopoulos | D. Lugo | E. Lam | S. Lane | P. Yeh | Rab K. Prinjha | Brian J.P. Huntly | S. Ftouni | Sarah Ftouni | Stanley Chun-Wei Lee | Chun Yew Fong | Omer Gilan | Enid Y.N. Lam | Dean Tyler | Kym Stanley | Devbarna Sinha | Jessica Kate Morison | George Giotopoulos | Dave Lugo | Christopher Carpenter | Richard A. Gregory | Steven W. Lane | Devbarna Sinha | C. Fong | J. Morison | C. Carpenter | Stanley C. Lee | Dean S. Tyler | Sarah Ftouni | Kym L. Stanley
[1] Daniel Rios,et al. Bioinformatics Applications Note Databases and Ontologies Deriving the Consequences of Genomic Variants with the Ensembl Api and Snp Effect Predictor , 2022 .
[2] G. Smyth,et al. ELDA: extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays. , 2009, Journal of immunological methods.
[3] C. So,et al. β-Catenin mediates the establishment and drug resistance of MLL leukemic stem cells. , 2010, Cancer cell.
[4] S. Robson,et al. Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia , 2011, Nature.
[5] William B. Smith,et al. Selective inhibition of BET bromodomains , 2010, Nature.
[6] Wei Shi,et al. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features , 2013, Bioinform..
[7] James D. Griffin,et al. Second generation inhibitors of BCR-ABL for the treatment of imatinib-resistant chronic myeloid leukaemia , 2007, Nature Reviews Cancer.
[8] T. Golub,et al. Transformation from committed progenitor to leukaemia stem cell initiated by MLL–AF9 , 2006, Nature.
[9] Kristian Helin,et al. Chromatin proteins and modifications as drug targets , 2013, Nature.
[10] Tony Kouzarides,et al. Targeting epigenetic readers in cancer. , 2012, The New England journal of medicine.
[11] Lanju Zhang,et al. A New Bliss Independence Model to Analyze Drug Combination Data , 2014, Journal of biomolecular screening.
[12] P. Vyas,et al. Coexistence of LMPP-like and GMP-like leukemia stem cells in acute myeloid leukemia. , 2011, Cancer cell.
[13] Bruce J. Melancon,et al. Small-molecule inhibition of Wnt signaling through activation of casein kinase 1α. , 2010, Nature chemical biology.
[14] Łukasz M. Boryń,et al. Transcriptional plasticity promotes primary and acquired resistance to BET inhibition , 2015, Nature.
[15] P. Johnston,et al. Cancer drug resistance: an evolving paradigm , 2013, Nature Reviews Cancer.
[16] Y. Benjamini,et al. Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .
[17] A. Sivachenko,et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples , 2013, Nature Biotechnology.
[18] S. Robson,et al. Recurrent mutations, including NPM1c, activate a BRD4-dependent core transcriptional program in acute myeloid leukemia , 2013, Leukemia.
[19] Cheng Cheng,et al. The landscape of somatic mutations in Infant MLL rearranged acute lymphoblastic leukemias , 2015, Nature Genetics.
[20] Wolfram Goessling,et al. The Wnt/β-Catenin Pathway Is Required for the Development of Leukemia Stem Cells in AML , 2010, Science.
[21] Aristotelis Tsirigos,et al. GenomicTools: a computational platform for developing high-throughput analytics in genomics , 2012, Bioinform..
[22] Christopher A. Miller,et al. VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing. , 2012, Genome research.
[23] Junwei Shi,et al. The mechanisms behind the therapeutic activity of BET bromodomain inhibition. , 2014, Molecular cell.
[24] Richard Durbin,et al. Sequence analysis Fast and accurate short read alignment with Burrows – Wheeler transform , 2009 .
[25] Laurie E Ailles,et al. Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML. , 2004, The New England journal of medicine.
[26] S. Armstrong,et al. Cell of origin determines clinically relevant subtypes of MLL-rearranged AML , 2013, Leukemia.
[27] H. Johnsen,et al. Cancer stem cell definitions and terminology: the devil is in the details , 2012, Nature Reviews Cancer.
[28] Clifford A. Meyer,et al. Model-based Analysis of ChIP-Seq (MACS) , 2008, Genome Biology.
[29] Terrence S. Furey,et al. The UCSC Table Browser data retrieval tool , 2004, Nucleic Acids Res..
[30] Rafael A. Irizarry,et al. Bioinformatics and Computational Biology Solutions using R and Bioconductor , 2005 .
[31] M. DePristo,et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. , 2010, Genome research.
[32] Gordon K. Smyth,et al. limma: Linear Models for Microarray Data , 2005 .
[33] W. Shi,et al. The Subread aligner: fast, accurate and scalable read mapping by seed-and-vote , 2013, Nucleic acids research.
[34] Christopher J. Ott,et al. An epigenetic mechanism of resistance to targeted therapy in T cell acute lymphoblastic leukemia , 2014, Nature Genetics.
[35] M. Dawson,et al. Cancer Epigenetics: From Mechanism to Therapy , 2012, Cell.
[36] M. Cleary,et al. Identification and characterization of leukemia stem cells in murine MLL-AF9 acute myeloid leukemia. , 2006, Cancer cell.
[37] A. Palumbo,et al. Abstract CT231: BET-bromodomain inhibitor OTX015 shows clinically meaningful activity at nontoxic doses: interim results of an ongoing phase I trial in hematologic malignancies , 2014 .
[38] S. Lowe,et al. RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia , 2011, Nature.
[39] David A. Orlando,et al. Selective Inhibition of Tumor Oncogenes by Disruption of Super-Enhancers , 2013, Cell.
[40] Di Wu,et al. ROAST: rotation gene set tests for complex microarray experiments , 2010, Bioinform..
[41] Pablo Tamayo,et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[42] Angelo J. Canty,et al. Stem cell gene expression programs influence clinical outcome in human leukemia , 2011, Nature Medicine.